The multicenter study called Invasive Monitoring Attenuation of Gene Expression included research by Dr. The results Annual Scientific Meeting of Annual Scientific Meeting the International Society for Heart and Lung Transplantation in Chicago and published online in the New England Journal of Medicine today.
(For those in the gene expression test group, biopsies were performed when the test showed an increased risk for rejection, or if there are other clinical indications of rejection via cardiogram or symptoms.. After the first year of transplant heart transplant patients risk of risk of 3 to 5 % for moderate or severe rejection. Rejection of a transplanted heart damage damage and eventual failure and loss of life. Is therefore for the rest of their lives, patients must be monitored for lead in rejecting its immunosuppressant therapy.
Investigators randomly 602 patients, the six months were up to five years since her heart transplant rejection monitoring undergo either with gene – expression profiling or routine endomyocardial biopsy in addition to clinical and echocardiographic assessment of organ function to associated.‘I am very honored to receive this award for part who I am to receive than,’says Peters ‘at the USC, the work with patients both from West Los Angeles and to the I to me has a so wide range of experience unique. ‘ unique. ‘.
More than 13,000 top researchers, physicians and other health professionals around the world -class research, treating recommendations and progress made toward a cure of diabetic divided at the 68. Union Scientific Sessions of the San Francisco, 1940.